This position statement outlines the role of TEVAR as a less invasive alternative to open surgery for thoracic aortic diseases.
No takes yet. Share an insight, caveat, or question.
Favors TEVAR over open repair when feasible; reinforces and extends guideline recommendations for thoracic aortic disease.
Grabenwöger et al. (2012) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: